Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Otonomy Inc files IPO - Form S-1/A


Friday, 1 Aug 2014 06:07am EDT 

Otonomy Inc:Offers 5,333,333 shares to be sold in the offering.IPO is expected to be between $14.00 and $16.00 per share.Says they have applied to list common stock on The NASDAQ Global Market under the symbol OTIC.Intend to use net proceeds to fund expenses in connection with obtaining regulatory approval and preparing for commercialization of AuriPro; OTO-104 clinical development, including completion of the OTO-104 Phase 2b clinical trial and.And initiation of one or more open-label, multiple-dose safety studies in Ménière’s patients; preclinical development and a Phase 1 clinical trial for OTO-311; and for research and development activities, working capital and other general corporate purposes.J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers of the offering and as representatives of the underwriters.Underwriters are J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Inc, Piper Jaffray & Co, Sanford C. Bernstein & Co., LLC. 

Company Quote

25.45
-0.47 -1.81%
1:22pm EDT